XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Certain Balance Sheet Accounts
 6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Certain Balance Sheet Accounts Certain Balance Sheet Accounts
Inventory

Substantially all of the Company's inventory consisted of finished goods as of June 30, 2023 and December 31, 2022.
Property and Equipment, net

Property and equipment consisted of the following as of:

June 30, 2023December 31, 2022
Tooling and manufacturing equipment$2,731 $2,731 
Furniture and fixtures639 639 
Computer equipment601 660 
Software106 106 
Leasehold improvements35 29 
Total property and equipment4,112 4,165 
Less accumulated depreciation and amortization(3,503)(3,057)
Property and equipment, net$609 $1,108 

Depreciation and amortization expense on property and equipment was $225 and $320 for the three months ended June 30, 2023 and June 30, 2022, respectively. For the three months ended June 30, 2023 and June 30, 2022, the Company allocated $148 and $208, respectively, of depreciation and amortization expense related to tooling and manufacturing equipment and software to cost of revenues.

Depreciation and amortization expense on property and equipment was $500 and $629 for the six months ended June 30, 2023 and June 30, 2022, respectively. For the six months ended June 30, 2023 and June 30, 2022, the Company allocated $330 and $398, respectively, of depreciation and amortization expense related to tooling and manufacturing equipment and software to cost of revenues.

Intangible Assets Subject to Amortization

Intangible assets were $2,253, net of accumulated amortization of $236 as of June 30, 2023 and $2,279, net of accumulated amortization of $206, as of December 31, 2022.

Capitalized software development costs were $1,873 on June 30, 2023 and December 31, 2022. The Company's internally developed software capitalized within intangible assets on the balance sheet is still in development and not ready for general release. As such, the Company has not recognized any amortization for the three or six months ended June 30, 2023 or 2022.

The Company did not recognize any impairment charges for intangible assets during the three or six months ended June 30, 2023 or 2022.

Accrued and Other Expenses

On October 1, 2021, the Company received a Warning Letter, later corrected in an amendment to the letter dated October 5, 2021 (the “Warning Letter”), from the U.S. Food and Drug Administration (the “FDA”) regarding the Owlet Smart Sock. During the fourth quarter of 2021, the Company agreed with certain customers and retailers to accept returns of the Owlet Smart Sock and Owlet Monitor Duo.

Accrued and other expenses, among other things, included accrued sales returns of $1,717 and $6,756 as of June 30, 2023 and December 31, 2022, respectively. Accrued sales returns included $36 and $4,958 as of June 30, 2023 and December 31, 2022, respectively, for product returns related to the Warning Letter.


Changes in accrued warranty were as follows:
For the Three Months Ended June 30,
20232022
Accrued warranty, beginning of period$592 $725 
Provision for warranties issued during the period81 193 
Settlements of warranty claims during the period(82)(143)
Accrued warranty, end of period$591 $775 
For the Six Months Ended June 30,
20232022
Accrued warranty, beginning of period$712 $661 
Provision for warranties issued during the period116 394 
Settlements of warranty claims during the period(237)(280)
Accrued warranty, end of period$591 $775